BioCentury | Apr 14, 2014
Financial News

AdvanDx completes venture financing

AdvanDx Inc. , Woburn, Mass. Business: Diagnostic Date completed: 4/8/14 Type: Venture financing Raised: $9 million Investors: Merck Global Health Innovation Fund; SLS Invest; LD Pension Fund Note: The company raised $9 million from a secured...
BioCentury | Apr 9, 2014
Financial News

AdvanDx secures $12 million in B-1 round

...round led by new investor Merck Global Health Innovation Fund. Existing investors SLS Ventures and LD Pensions...
BioCentury | Jun 25, 2012
Financial News

Santaris completes venture financing

Santaris Pharma A/S , Horsholm, Denmark Business: Cancer, Infectious, Endocrine/Metabolic Date completed: 6/20/12 Type: Venture financing Raised: $12 million Investors: Sunstone; Novo A/S; Gilde; Forbion Capital Partners; LD Pension Fund; Global Life Science Ventures; Seventure Partners;...
BioCentury | Jun 21, 2012
Financial News

Santaris raises $12 million

Santaris Pharma A/S (Horsholm, Denmark) raised $12 million through the sale of convertible bonds to existing investors Sunstone Capital; Novo A/S; Gilde; Forbion Capital Partners; LD Pension Fund; Global Life Science Venture; Seventure; and company...
BioCentury | Nov 8, 2010
Finance

Zeal for Zealand

...DKK134 million ($24.5 million) in cash. Other investors include Sunstone Capital; IDinvest Partners; CDC Innovation; LD Pensions...
BioCentury | Aug 24, 2009
Financial News

AdvanDx financial update

...bringing the total raised in the round to $23 million. Existing investors SLS Venture and LD Pensions...
BioCentury | Feb 9, 2009
Finance

Ebb & Flow

Novartis (NYSE:NVS; SWX:NOVN) caused some stir last week when it unveiled plans for a $5 billion bond issue that the company said will be used "for general corporate purposes outside of Switzerland." With Pfizer (NYSE:PFE)...
BioCentury | Feb 5, 2009
Financial News

Symphogen raises EUR 33 million

Symphogen (Copenhagen, Denmark) raised EUR 33 million ($42.1 million) in a Series E round led by existing investor Essex Woodlands Health Ventures. LD Pension Fund; Scandinavian Life Science Venture; Novo A/S; Sunstone; Gilde; and Danske...
BioCentury | Dec 15, 2008
Finance

Ebb & Flow

In good economic times, companies that run into problems can often avoid tough decisions - such as dropping programs or employees, or shutting their doors - by raising money from less savvy investors. Meanwhile, disgruntled investors can...
BioCentury | Dec 19, 2007
Financial News

Santaris raises EUR 20.4 million

Santaris (Horsholm, Denmark) raised EUR 20.4 million ($29.4 million) in a series C round. New investor Gilde joined existing investors BankInvest; Novo A/S; LD Pension Fund; Forbion Capital Partners; Global Life Science Venture; Sunstone Capital;...
Items per page:
1 - 10 of 28
BioCentury | Apr 14, 2014
Financial News

AdvanDx completes venture financing

AdvanDx Inc. , Woburn, Mass. Business: Diagnostic Date completed: 4/8/14 Type: Venture financing Raised: $9 million Investors: Merck Global Health Innovation Fund; SLS Invest; LD Pension Fund Note: The company raised $9 million from a secured...
BioCentury | Apr 9, 2014
Financial News

AdvanDx secures $12 million in B-1 round

...round led by new investor Merck Global Health Innovation Fund. Existing investors SLS Ventures and LD Pensions...
BioCentury | Jun 25, 2012
Financial News

Santaris completes venture financing

Santaris Pharma A/S , Horsholm, Denmark Business: Cancer, Infectious, Endocrine/Metabolic Date completed: 6/20/12 Type: Venture financing Raised: $12 million Investors: Sunstone; Novo A/S; Gilde; Forbion Capital Partners; LD Pension Fund; Global Life Science Ventures; Seventure Partners;...
BioCentury | Jun 21, 2012
Financial News

Santaris raises $12 million

Santaris Pharma A/S (Horsholm, Denmark) raised $12 million through the sale of convertible bonds to existing investors Sunstone Capital; Novo A/S; Gilde; Forbion Capital Partners; LD Pension Fund; Global Life Science Venture; Seventure; and company...
BioCentury | Nov 8, 2010
Finance

Zeal for Zealand

...DKK134 million ($24.5 million) in cash. Other investors include Sunstone Capital; IDinvest Partners; CDC Innovation; LD Pensions...
BioCentury | Aug 24, 2009
Financial News

AdvanDx financial update

...bringing the total raised in the round to $23 million. Existing investors SLS Venture and LD Pensions...
BioCentury | Feb 9, 2009
Finance

Ebb & Flow

Novartis (NYSE:NVS; SWX:NOVN) caused some stir last week when it unveiled plans for a $5 billion bond issue that the company said will be used "for general corporate purposes outside of Switzerland." With Pfizer (NYSE:PFE)...
BioCentury | Feb 5, 2009
Financial News

Symphogen raises EUR 33 million

Symphogen (Copenhagen, Denmark) raised EUR 33 million ($42.1 million) in a Series E round led by existing investor Essex Woodlands Health Ventures. LD Pension Fund; Scandinavian Life Science Venture; Novo A/S; Sunstone; Gilde; and Danske...
BioCentury | Dec 15, 2008
Finance

Ebb & Flow

In good economic times, companies that run into problems can often avoid tough decisions - such as dropping programs or employees, or shutting their doors - by raising money from less savvy investors. Meanwhile, disgruntled investors can...
BioCentury | Dec 19, 2007
Financial News

Santaris raises EUR 20.4 million

Santaris (Horsholm, Denmark) raised EUR 20.4 million ($29.4 million) in a series C round. New investor Gilde joined existing investors BankInvest; Novo A/S; LD Pension Fund; Forbion Capital Partners; Global Life Science Venture; Sunstone Capital;...
Items per page:
1 - 10 of 28